Portside Wealth Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
8,053
+2,490
+45% +$306K 0.13% 172
2026
Q1
$655K Sell
5,563
-150
-3% -$21K 0.09% 217
2025
Q4
$936K Buy
5,713
+3,511
+159% +$550K 0.13% 178
2025
Q3
$294K Buy
+2,202
New +$267K 0.04% 377

Other funds holding RGEN

Portside Wealth Group's RGEN Position: Q2 2026 in Review

Portside Wealth Group increased its Repligen (RGEN) stake by 45% in Q2 2026, buying an estimated $306K and bringing the position to 8,053 shares worth $1.1M. The position accounts for 0.13% of the portfolio, ranked #172.

Portside Wealth Group first reported a position in RGEN in Q3 2025 and has held it in 4 quarters since. 48 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Portside Wealth Group held 8,053 shares of Repligen worth $1.1M as of Q2 2026.
  • Portside Wealth Group bought 2,490 Repligen shares in Q2 2026, an estimated $306K.
  • Repligen made up 0.13% of Portside Wealth Group's portfolio in Q2 2026, its #172 holding.
  • Portside Wealth Group first reported a position in Repligen in Q3 2025 and has held it in 4 quarters since.
  • 48 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Portside Wealth Group's 13F filing for Q2 2026, filed 14 Jul 2026.